Coronary artery bypass grafting (CABG) triggers a systemic inflammatory response that may contribute to adverse outcomes. Dendritic cells (DC) and monocytes are immunoregulatory cells potentially affected by CABG, contributing to an altered immune state. This study investigated changes in DC and monocyte responses in CABG patients at 5 time-points: admission, peri-operative, ICU, day 3 and day 5. Whole blood from 49 CABG patients was used in an ex vivo whole blood culture model to prospectively assess DC and monocyte responses. Lipopolysaccharide (LPS) was added in parallel to model responses to an infectious complication. Co-stimulatory and adhesion molecule expression and intracellular mediator production was measured by flow cytometry. CABG modulated monocyte and DC responses. In addition, DC and monocytes were immunoparalysed, evidenced by failure of co-stimulatory and adhesion molecules (eg HLA-DR), and intracellular mediators (eg IL-6) to respond to LPS stimulation. DC and monocyte modulation was associated with prolonged ICU length of stay and post-operative atrial fibrillation. DC and monocyte cytokine production did not recover by day 5 post-surgery. This study provides evidence that CABG modulates DC and monocyte responses. Using an ex vivo model to assess immune competency of CABG patients may help identify biomarkers to predict adverse outcomes.
Coronary artery bypass grafting is associated with immunoparalysis of monocytes and dendritic cells.
阅读:3
作者:Perros Alexis J, Esguerra-Lallen Arlanna, Rooks Kelly, Chong Fenny, Engkilde-Pedersen Sanne, Faddy Helen M, Hewlett Elise, Naidoo Rishendran, Tung John-Paul, Fraser John F, Tesar Peter, Ziegenfuss Marc, Smith Susan, O'Brien Donalee, Flower Robert L, Dean Melinda M
| 期刊: | Journal of Cellular and Molecular Medicine | 影响因子: | 4.200 |
| 时间: | 2020 | 起止号: | 2020 Apr;24(8):4791-4803 |
| doi: | 10.1111/jcmm.15154 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
